AI
AGIO icon

Axiom Investors’s Agios Pharmaceuticals AGIO Stock Holding History

Axiom Investors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-16,082
Closed -$802K – 119
2019
Q2 		$802K Sell
16,082
-1,765
-10% -$94.3K 0.02% 117
2019
Q1 		$1.2M Buy
17,847
+6,575
+58% +$383K 0.04% 115
2018
Q4 		$520K Sell
11,272
-12,636
-53% -$780K 0.02% 125
2018
Q3 		$1.84M Sell
23,908
-1,800
-7% -$145K 0.05% 121
2018
Q2 		$2.17M Buy
+25,708
New +$2.24M 0.07% 124

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Axiom Investors's AGIO Position: Q3 2019 in Review

Axiom Investors sold out of Agios Pharmaceuticals (AGIO) in Q3 2019, closing a stake of 16,082 shares — an estimated $802K sold.

Axiom Investors first reported a position in AGIO in Q2 2018 and held it in 5 quarters. The position peaked at $2.17M in Q2 2018. 189 funds tracked by Wall St. Rank hold AGIO as of Q3 2019.

  • Axiom Investors reported no remaining Agios Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Axiom Investors sold 16,082 Agios Pharmaceuticals shares in Q3 2019, an estimated $802K.
  • Axiom Investors first reported a position in Agios Pharmaceuticals in Q2 2018 and held it in 5 quarters.
  • Axiom Investors's Agios Pharmaceuticals position peaked at $2.17M in Q2 2018.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2019.

Based on Axiom Investors's 13F filing for Q3 2019, filed 13 Nov 2019.